AGC Biologics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2,500

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

  • Investments
  • 3

AGC Biologics General Information

Description

Developer and manufacturer of biopharmaceuticals, from pre-clinical to commercial. The company is a global contract development and manufacturing organization (CDMO) and meets the growing demand for plasmid DNA offerings by expanding CDMO services, enabling to help clients to bring safe and effective biological products to the market.

Contact Information

Website
www.agcbio.com
Formerly Known As
CMC Biologics
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 21511 23rd Drive Southeast
  • Bothell, WA 98021
  • United States
+1 (425)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 21511 23rd Drive Southeast
  • Bothell, WA 98021
  • United States
+1 (425)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AGC Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AGC Biologics‘s full profile, request access.

Request a free trial

AGC Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and manufacturer of biopharmaceuticals, from pre-clinical to commercial. The company is a global contract deve
Other Pharmaceuticals and Biotechnology
Bothell, WA
2,500 As of 2024

Bucks, United Kingdom
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AGC Biologics Competitors (13)

One of AGC Biologics’s 13 competitors is Biopharm Services, a Corporation company based in Bucks, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biopharm Services Corporation Bucks, United Kingdom
Codexis Formerly VC-backed Redwood City, CA
BioDuro-Sundia Private Equity-Backed Irvine, CA
NextPharma Private Equity-Backed London, United Kingdom
Cell Therapies Corporation Melbourne, Australia
You’re viewing 5 of 13 competitors. Get the full list »

AGC Biologics Patents

  • 38

    Total Documents Applications and Grants

  • Total Patents Families

  • 25

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

AGC Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4228794-A1 Continuous high cell-density culture with dual-vessel tangential flow filtration Pending 15-Oct-2020
US-20240043896-A1 Continuous high cell-density culture with dual-vessel tangential flow filtration Pending 15-Oct-2020
US-20210062217-A1 Bidirectional chef1 vectors Pending 10-Jan-2018
EP-3737767-A1 Bidirectional chef1 vectors Pending 10-Jan-2018
AU-2019206443-A1 Bidirectional chefl vectors Pending 10-Jan-2018 C12N15/85
To view AGC Biologics’s complete patent history, request access »

AGC Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AGC Biologics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AGC Biologics‘s full profile, request access.

Request a free trial

AGC Biologics Investments & Acquisitions (3)

AGC Biologics’s most recent deal was a Corporate Asset Purchase with Novartis Gene (Cell and Gene Therapy Commercial Manufacturing Facility in Longmont, Colorado). The deal was made on 09-Aug-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Novartis Gene (Cell and Gene Therapy Commercial Manufacturing Facility in Longmont, Colorado) 09-Aug-2021 Corporate Asset Purchase Buildings and Property
MolMed 31-Jul-2020 Merger/Acquisition Biotechnology
AstraZeneca (pharmaceutical plant in Boulder) 01-May-2020 Corporate Asset Purchase Buildings and Property
To view AGC Biologics’s complete investments and acquisitions history, request access »

AGC Biologics FAQs

  • When was AGC Biologics founded?

    AGC Biologics was founded in 2001.

  • Where is AGC Biologics headquartered?

    AGC Biologics is headquartered in Bothell, WA.

  • What is the size of AGC Biologics?

    AGC Biologics has 2,500 total employees.

  • What industry is AGC Biologics in?

    AGC Biologics’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is AGC Biologics a private or public company?

    AGC Biologics is a Private company.

  • What is AGC Biologics’s current revenue?

    The current revenue for AGC Biologics is .

  • How much funding has AGC Biologics raised over time?

    AGC Biologics has raised $30.1M.

  • Who are AGC Biologics’s investors?

    European Equity Partners and InnoVentures Capital Partners have invested in AGC Biologics.

  • Who are AGC Biologics’s competitors?

    Biopharm Services, Codexis, BioDuro-Sundia, NextPharma, and Cell Therapies are some of the 13 competitors of AGC Biologics.

  • When was AGC Biologics acquired?

    AGC Biologics was acquired on 22-Dec-2016.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »